Debbie Chirnomas

Debbie Chirnomas has extensive work experience in the medical field. Debbie is currently the Chief Medical Officer at Faeth Therapeutics since May 2023. Prior to that, they worked at Arvinas from February 2020 to June 2023 as the VP of Oncology Clinical Development. From October 2018 to February 2020, they held the position of VP of Clinical Development and Medical Affairs at Gamida Cell Ltd. Before that, they worked at Pfizer for several roles including MD Clinician Oncology from June 2015 to February 2020 and Medical Strategy Head for Xtandi from February 2018 to October 2018. Furthermore, they served as the Director of Pediatric Stem Cell Transplant at Yale University School of Medicine from September 2010 to June 2015. Debbie also worked at Boston Children's Hospital as the Associate Director of the Thalassemia program from an unspecified date in 2006 to April 2010, and as an Attending Physician in the Stem Cell Transplant program from July 2005 to April 2010.

Debbie Chirnomas holds a Doctor of Medicine (M.D.) degree from Albert Einstein College of Medicine. Debbie also pursued a Master of Public Health (MPH) degree with a specialization in Clinical effectiveness from Harvard T.H. Chan School of Public Health. Before that, they completed their undergraduate education at the University of Pennsylvania, where they obtained a Bachelor of Arts (B.A.) degree in Diplomatic History. Additionally, they earned a Bachelor of Science and Economics (B.S.E.) degree in Health Care Management from The Wharton School.